EyePoint, Inc. (EYPT) Presents at UBS World Biopharma Convention 2026 Transcript
Comply withQ3: 2026-11-12 Earnings AbstractEPS of -$1.07 misses by $0.14 | Income of $756.00K (-21.74% Y/Y) beats by $522.92K EyePoint, Inc....
Comply withQ3: 2026-11-12 Earnings AbstractEPS of -$1.07 misses by $0.14 | Income of $756.00K (-21.74% Y/Y) beats by $522.92K EyePoint, Inc....
Albert RiceUBS Funding Financial institution, Analysis Division So we're 10 months into the 12 months. How has the 12 months...
Unknown Analyst I suppose perhaps simply to kick off, like new administration. There's been a number of transferring items. You...
International brokerage agency UBS has upgraded its score on Financial institution of Baroda (BOB) to ‘Purchase’ from an earlier ‘Impartial’,...
Investing.com-- UBS analysts famous that the worldwide vitality transition to renewables from fossil fuels is in full movement, and that...
Investing.com -- Gestamp Automoción S.A. (BME:) noticed its shares fall over 5% following downgrades from each Barclays (LON:) and UBS, because...
Brokerage UBS prefers Solar Pharma and Cipla amongst Indian drugmakers and expects the shares to return 26% and 23%, respectively,...
UBS Area at Belmont Park BELMONT PARK, NY (CelebrityAccess) — UBS Area and...
From left to proper: Johan Pihl, Doconomy's chief inventive officer and co-founder, and Mathias Wikstrom, chief govt officer and co-founder.DoconomySwedish...